GreenLight Clinical, a physician-led solutions-focused Clinical CRO, and Taimei Technology have joined forces to accelerate clinical research. This partnership leverages Taimei’s AI-driven EDC solution and platform and substantial APAC regional reach to meet sponsors’ evolving needs in research data management. With this collaboration, GreenLight Clinical aims to enhance its ability to streamline data management processes and deliver greater value to its clients, particularly in the APAC region. By integrating Taimei’s innovative AI-driven EDC solution into their service offerings, GreenLight Clinical is poised to elevate the quality and efficiency of clinical trials, ultimately advancing healthcare outcomes, and bringing innovative treatments to patients worldwide.
From Robert Lin, CEO of GreenLight Clinical,
“The GreenLight Clinical and Taimei partnership combines expertise in research database management, technology strategy, and innovative deployment to meet sponsors’ evolving needs in research data management. This partnership is powerful, leveraging Taimei’s leading AI-driven EDC solution and platform, coupled with substantial APAC regional reach, aligning perfectly with GreenLight Clinical’s renewed focus in the APAC region.”
From Ipsa Nayak, Head of Technical Services at GreenLight Clinical,
“As the Head of Technical Services, I am excited about the strategic partnership between Greenlight Clinical and Taimei. This collaboration allows us to leverage Taimei’s cutting-edge electronic data capture technologies, enhancing our ability to streamline data management processes and deliver even greater value to our clients. By integrating these innovative AI driven solutions into our service offerings, we are poised to elevate the quality and efficiency of clinical trials, ultimately advancing healthcare outcomes and bringing innovative treatments to patients worldwide.”
From Nate Zhang, GM of Overseas Business at Taimei Technology,
“We’re thrilled to announce our partnership with GreenLight Clinical in APAC, marking a significant step in Taimei’s globalization strategy. This collaboration not only strengthens our presence in the region but also underscores our commitment to advancing clinical research worldwide. Our AI-driven eClinical software suite revolutionizes clinical data management and clinical trial operations, improving efficiency, accuracy, and cost-effectiveness at every stage. Together with GreenLight Clinical, we’re dedicated to driving innovation, accelerating the development of life-changing therapies and ultimately improving patient outcomes globally.”
From Sam Xu, Head of Business Development APAC at Taimei Technology,
“We are pleased to announce the signing of this agreement, marking a significant milestone in our quest for advancements in healthcare. This collaboration underscores our collective dedication to pioneering research, patient-centricity, and pursuing breakthrough therapies that can transform lives. Together, we are poised to redefine the future of clinical trials, ensuring a brighter, healthier tomorrow for all.”
GreenLight Clinical will participate in Taimei’s inaugural Clinical Data Summit on April 23 in Singapore and DIA China, including a visit to Taimei Shanghai HQ on May 15. Robert Lin, GreenLight Clinical CEO, will also speak in the upcoming Taimei-hosted webinar “Bridging China and Australia: Recommendations for maximizing collaboration and successful clinical trials in Australia.”
GreenLight Clinical has offices in Australia and the USA, and presence in the APAC region. They support clinical trials for biotech and medtech companies. GLC is well-established with strengths in ophthalmology, rare diseases, and early-phase clinical trials. Their footprint expands globally to include the vibrant US and Asia Pacific regions. Combining medical expertise and deep industry knowledge, their agile and flexible approach allows them to adapt to different study requirements and timelines, ensuring a smooth and successful trial process. GLC conducts all trials to ICH/GP protocol and is ISO 9001:2015 quality management approved. At GLC, they ensure that an experienced team will look after your Australian trials. We can support Phase I to Phase III trials throughout Australia.
Taimei Technology has developed a leading integrated digital platform dedicated to clinical research with in-depth insights into drug R&D, pharmacovigilance, marketing, and sales. Our digital cooperation platform, TrialOS, integrates AI, big data, cloud computing, and mobile Internet technologies to provide innovative solutions to industry stakeholders across the entire product life cycle. Through digital technology solutions and innovative services, we empower new drug research and development, accelerate the process of new medicine launches for our customers, and improve business performance. Together, we fulfill the vision of “building a digital ecosystem for the life science industry” to benefit patients.
Taimei Technology has also developed partnerships with CSI Medical Research and IHiS.
